Description
An SPHK2 inhibitor (Ki = 0.4 μM for the recombinant mouse enzyme); selective for SPHK2 over SPHK1 (Kis = >20 μM); decreases S1P and increases sphingosine levels in U937 monocytic leukemia cells in a concentration-dependent manner; reduces blood S1P levels in Sphk1-/-, but not Sphk2-/-, mice at 5 mg/kg; increases blood S1P levels in wild-type mice and rats
Formal name: (2S)-2-[3-[4-(octyloxy)-3-(trifluoromethyl)phenyl]-1,2,4-oxadiazol-5-yl]-1-pyrrolidinecarboximidamide, monohydrochloride
Synonyms:
Molecular weight: 490
CAS: 1897379-34-8
Purity: ≥98%
Formulation: A crystalline solid